Literature DB >> 7908433

Abecarnil is a full agonist at some, and a partial agonist at other recombinant GABAA receptor subtypes.

I Pribilla1, R Neuhaus, R Huba, M Hillmann, J D Turner, D N Stephens, H H Schneider.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7908433     DOI： 10.1007/978-3-642-78451-4_5

Source DB:  PubMed          Journal:  Psychopharmacol Ser        ISSN： 0931-6795


× No keyword cloud information.
  6 in total

1.  Abecarnil, a beta-carboline derivative, does not exhibit anticonvulsant tolerance or withdrawal effects in mice.

Authors:  F Natolino; A Zanotti; A Contarino; M Lipartiti; P Giusti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

Review 2.  Heterogeneity of GABAA-receptors: cell-specific expression, pharmacology, and regulation.

Authors:  H Mohler; F Knoflach; J Paysan; K Motejlek; D Benke; B Lüscher; J M Fritschy
Journal:  Neurochem Res       Date:  1995-05       Impact factor: 3.996

3.  Selective stimulation of central GABAAα2,3,5 receptors increases intake and motivation to consume sucrose solution in rats.

Authors:  Tyler S Nelson; Sarah E Holstein; John-Paul Baird; David W Pittman
Journal:  Neuroscience       Date:  2019-04-29       Impact factor: 3.590

4.  Benzodiazepine-GABAA receptor complex ligands in two models of anxiety.

Authors:  M Nazar; M Jessa; A Płaźnik
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

5.  Discriminative stimulus effects of midazolam and abecarnil in rats treated chronically with diazepam or abecarnil.

Authors:  D A Lytle; M W Emmett-Oglesby; D N Stephens
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

Review 6.  Anxioselective anxiolytics: on a quest for the Holy Grail.

Authors:  Phil Skolnick
Journal:  Trends Pharmacol Sci       Date:  2012-09-14       Impact factor: 14.819
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.